170 related articles for article (PubMed ID: 23573318)
1. UNC51-like kinase 1 as a potential prognostic biomarker for hepatocellular carcinoma.
Xu H; Yu H; Zhang X; Shen X; Zhang K; Sheng H; Dai S; Gao H
Int J Clin Exp Pathol; 2013; 6(4):711-7. PubMed ID: 23573318
[TBL] [Abstract][Full Text] [Related]
2. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
[TBL] [Abstract][Full Text] [Related]
3. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
4. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
5. High VRK1 expression contributes to cell proliferation and survival in hepatocellular carcinoma.
Huang W; Cui X; Chen Y; Shao M; Shao X; Shen Y; Liu Q; Wu M; Liu J; Ni W; Lu C; Wan C
Pathol Res Pract; 2016 Mar; 212(3):171-8. PubMed ID: 26706601
[TBL] [Abstract][Full Text] [Related]
6. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
Xue ST; Li K; Gao Y; Zhao LY; Gao Y; Yi H; Jiang JD; Li ZR
Autophagy; 2020 Oct; 16(10):1823-1837. PubMed ID: 31986961
[TBL] [Abstract][Full Text] [Related]
7. The Role of Autophagy in Hepatocellular Carcinoma.
Lee YJ; Jang BK
Int J Mol Sci; 2015 Nov; 16(11):26629-43. PubMed ID: 26561802
[TBL] [Abstract][Full Text] [Related]
8. Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.
Liu B; Zhang J; Huang C; Liu H
PLoS One; 2012; 7(8):e43147. PubMed ID: 22912812
[TBL] [Abstract][Full Text] [Related]
9. Canopy Homolog 2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma with Tumor Hemorrhage.
Wang D; Wang ZM; Zhang S; Wu HJ; Tao YM
Cell Physiol Biochem; 2018; 50(6):2017-2028. PubMed ID: 30415246
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance and clinical relevance of Sprouty 2 protein expression in human hepatocellular carcinoma.
Song K; Gao Q; Zhou J; Qiu SJ; Huang XW; Wang XY; Fan J
Hepatobiliary Pancreat Dis Int; 2012 Apr; 11(2):177-84. PubMed ID: 22484587
[TBL] [Abstract][Full Text] [Related]
12. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
[TBL] [Abstract][Full Text] [Related]
13. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
15. Intensive expression of UNC-51-like kinase 1 is a novel biomarker of poor prognosis in patients with esophageal squamous cell carcinoma.
Jiang S; Li Y; Zhu YH; Wu XQ; Tang J; Li Z; Feng GK; Deng R; Li DD; Luo RZ; Zhang MF; Qin W; Wang X; Jia WH; Zhu XF
Cancer Sci; 2011 Aug; 102(8):1568-75. PubMed ID: 21518141
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of UHRF1 predicts unfavorable prognosis for patients with hepatocellular carcinoma.
Liang D; Xue H; Yu Y; Lv F; You W; Zhang B
Int J Clin Exp Pathol; 2015; 8(8):9416-21. PubMed ID: 26464697
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
18. Kindlin-2: a novel prognostic biomarker for patients with hepatocellular carcinoma.
Ge YS; Liu D; Jia WD; Li JS; Ma JL; Yu JH; Xu GL
Pathol Res Pract; 2015 Mar; 211(3):198-202. PubMed ID: 25618552
[TBL] [Abstract][Full Text] [Related]
19. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
[TBL] [Abstract][Full Text] [Related]
20. Serine-arginine protein kinase 1 is associated with hepatocellular carcinoma progression and poor patient survival.
Zhang J; Jiang H; Xia W; Jiang Y; Tan X; Liu P; Jia H; Yang X; Shen G
Tumour Biol; 2016 Jan; 37(1):283-90. PubMed ID: 26201897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
